You are here

  • Home
  • Archive
  • Volume 8, Issue 6
  • Conventional cervical smears were better than monolayer cytology or human papillomavirus testing for detecting cervical intraepithelial neoplasia

Article Text

Article menu
Download PDFPDF
Diagnosis
Conventional cervical smears were better than monolayer cytology or human papillomavirus testing for detecting cervical intraepithelial neoplasia

https://doi.org/10.1136/ebm.8.6.187

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    (2003) BMJ 326, 733. Coste J, Cochand-Priollet B, de Cremoux P, et al.. Cross sectional study of conventional cervical smear, monolayer cytology, and human papillomavirus DNA testing for cervical cancer screening.. ;. :. –6.
    OpenUrlFREE Full Text

    
 
 QUESTION: In women referred for colposcopy or presenting for routine smears, is monolayer cytology (MLC) or human papillomavirus (HPV) testing more accurate than the conventional cervical smear (CCS) test for detecting cervical neoplasia?

    Design

    Blinded comparison of the CCS test, MLC, and HPV testing with colposcopy and histology as the reference standard.

    Setting

    2 university centres and 2 private practices in France.

    Participants

    828 women (mean age 38 y) who had been referred for colposcopy and 1757 women (mean age 33 y) who presented for routine smears.

    Description of tests and diagnostic standard

    All women were evaluated by the 3 methods (CCS test, MLC, and HPV testing), and by colposcopy followed by biopsy if abnormalities were detected. After the CCS test, the remaining portion of the sample was used for the monolayer slide and for …

    View Full Text

    Footnotes

    • Sources of funding: Direction Générale de la Santé and Programme Hospitalier de Recherche Clinique, French Ministry of Health and Association pour la Recherche sur le Cancer.

    • For correspondence: Professor J Coste, Hopital Cochin, Paris, France.coste{at}cochin.univ-paris5.fr

    • Abstract and commentary also appear in ACP Journal Club.